Industry news

06 May 2014

Surgeon reports high patient satisfaction with hydrogel corneal inlay

Healio.com

Overall patient satisfaction is 98% after implantation with the Raindrop inlay, according to a surgeon here. 

Angel Investors Look At Biotech

Gail Dutton / Life Science Leader

Angel groups are investing in biotech and are staying involved longer than ever before, creating new collaborations and financing options that raise more money than initial and subsequent rounds. Some say that today’s angels are similar to venture capitalists in the early 1990s.

Less is more for VCs investing in biotech

Thornton McEnery, Irina Ivanova / Crain's New York Business

Even in an off-quarter, biotech showed itself to be a key driver of New York's growing tech sector, and that momentum will need to continue in the face of stiff market headwinds.

New analysis incorporates real world insights from industry leaders

The Pharmaceutical Research and Manufacturers of America (PhRMA)

Today the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that outlines two potential growth trajectories for the U.S. biopharmaceutical sector and the top policy factors that enable the industry to innovate and, in turn, contribute to the U.S. economy.

PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth

Melanie Sena, BioPharm International

The Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that outlines two potential growth trajectories for the US biopharmaceutical sector. Developed by the Battelle Technology Partnership Practice, the report finds that coverage and payment policies, a science-based regulatory system, and strong intellectual property (IP) protections drive US leadership in biopharmaceutical innovation, and if negative trends in these key policy areas continue, jobs supported by the industry would decrease over the next decade. 

Experts offered a transfer to the federal level funding therapy ten rare diseases

market-access-solutions.com

Russian experts are going to appeal to the government proposal to transfer funding to the federal level of the ten most expensive rare diseases included in the list of 24 life-threatening and rare chronic progressive diseases that can shorten life expectancy of a citizen or disability. This message on April 3 , Deputy Director General of the Institute of EurAsEC Elena Krasil'nikova during the "round table" dedicated treatment of rare diseases.

Far East’s Nuclear Medicine Center to use domestic equipment

Marchmont Innovation News

The partners in the large Nuclear Medicine Center project in Vladivostok in Russia’s Far East have agreed that the future facility will use Russian equipment, the official website of the Primorsky regional administration  announced  earlier this week. 

Microsoft backs Russian-based research into Alzheimer’s

Marchmont Innovation News

Russian scientists from Novosibirsk and Moscow have received a grant from Microsoft for the use of its Windows Azure cloud platform in their research into the human genes responsible for the Alzheimer’s disease. They can use the platform for 12 months, Microsoft  announced. 
 

New Ryazan factory to make nanobased drugs

Marchmont Innovation News

OOO Fort, a Russian company, is launching a new pharmaceutical facility outside the city of Ryazan in Central Russia later this week, the Uzrf.ru portal for Russian healthcare institutions  reported . 

Patient-centric Engagement and the Digital Age

Kai Langel, Applied Clinical Trials

The Internet and various services using it as a platform evolve at such a rapid pace that it is difficult to keep track of everything and to understand its significance to clinical trials. One of the key aspects to consider is access to the Internet. In 1995, there were 16 million Internet users or 0.4% of the world’s population. In just 17 years, this figure has grown to 2.4 billion and 34.3% adoption. At the current rate, each year, the penetration percentage sees a 2-4% growth.